STAT3 speeds up progression of osteoarthritis through NF‑κB signaling pathway

Wang,Feida; Guo,Zhenye; Yuan,Yinpeng

doi:10.3892/etm.2019.8268

STAT3 speeds up progression of osteoarthritis through NF‑κB signaling pathway

Authors:
- Feida Wang
- Zhenye Guo
- Yinpeng Yuan
View Affiliations

Affiliations: Department of Osteopathy, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China
Published online on: December 2, 2019 https://doi.org/10.3892/etm.2019.8268
Pages: 722-728
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Osteoarthritis (OA) is the most common motor system disease in the elderly, with a high incidence and a huge social and economic burden. Therefore, it is urgent to study its potential pathogenesis to improve the therapeutic effect of the disease. In this study, we constructed a number of regulator‑mediated OA dysfunction modules, and carried out in‑depth analysis in order to examine the disease development process. Differential expression analysis, co‑expression analysis and enrichment analysis were combined to screen genes related to disease progression. Subsequently, key regulatory factors in the process of OA were identified based on the pivotal regulators that may manipulate important parts of the module subnetwork. A total of 16 OA dysfunction modules were obtained, involving the aggregation of 3,239 module genes. Then, enrichment analysis showed that module genes were significantly involved in apoptosis, inflammation‑related functions and signaling pathways. Finally, we revealed a series of regulators, including 842 ncRNA (miR‑132‑3p, miR‑130a‑3p and miR‑590‑3p), 59 transcription factors (NFKB1, RELA and STAT3). We consider that STAT3 is the core transcription factor and promotes the development of OA through the signal of NF‑κB. Overall, our results provide biologists and pharmacists with a new way of thinking to reveal the disease process of OA, and provide a wider range of candidate targets for follow‑up research.

View Figures

View References

1	Litwic A, Edwards MH, Dennison EM and Cooper C: Epidemiology and burden of osteoarthritis. Br Med Bull. 105:185–199. 2013. View Article : Google Scholar : PubMed/NCBI
2	Dieppe PA and Lohmander LS: Pathogenesis and management of pain in osteoarthritis. Lancet. 365:965–973. 2005. View Article : Google Scholar : PubMed/NCBI
3	Prieto-Alhambra D, Judge A, Javaid MK, Cooper C, Diez-Perez A and Arden NK: Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: Influences of age, gender and osteoarthritis affecting other joints. Ann Rheum Dis. 73:1659–1664. 2014. View Article : Google Scholar : PubMed/NCBI
4	Pérez Martín Á: [Symptoms. Localizations: Knee, hip, hands, spine, other localizations]. Aten Primaria. 46 (Suppl 1):11–17. 2014.PubMed/NCBI
5	Flugsrud GB, Nordsletten L, Reinholt FP, Risberg MA, Rydevik K and Uhlig T: Osteoarthritis. Tidsskr Nor Laegeforen. 130:2136–2140. 2010.(In Norwegian). View Article : Google Scholar : PubMed/NCBI
6	Bijlsma JW, Berenbaum F and Lafeber FP: Osteoarthritis: An update with relevance for clinical practice. Lancet. 377:2115–2126. 2011. View Article : Google Scholar : PubMed/NCBI
7	Thomas AC, Hubbard-Turner T, Wikstrom EA and Palmieri-Smith RM: Epidemiology of posttraumatic osteoarthritis. J Athl Train. 52:491–496. 2017. View Article : Google Scholar : PubMed/NCBI
8	Buckwalter JA and Martin JA: Osteoarthritis. Adv Drug Deliv Rev. 58:150–167. 2006. View Article : Google Scholar : PubMed/NCBI
9	Felson DT: An update on the pathogenesis and epidemiology of osteoarthritis. Radiol Clin North Am. 42:1–9. 2004. View Article : Google Scholar : PubMed/NCBI
10	Steinberg J and Zeggini E: Functional genomics in osteoarthritis: Past, present, and future. J Orthop Res. 34:1105–1110. 2016. View Article : Google Scholar : PubMed/NCBI
11	Kloek CJ, Bossen D, Veenhof C, van Dongen JM, Dekker J and de Bakker DH: Effectiveness and cost-effectiveness of a blended exercise intervention for patients with hip and/or knee osteoarthritis: Study protocol of a randomized controlled trial. BMC Musculoskelet Disord. 15:2692014. View Article : Google Scholar : PubMed/NCBI
12	Grazina R, Andrade R, Bastos R, Costa D, Pereira R, Marinhas J, Maestro A and Espregueira-Mendes J: Clinical management in early OA. Adv Exp Med Biol. 1059:111–135. 2018. View Article : Google Scholar : PubMed/NCBI
13	Teoh LSG, Eyles JP, Makovey J, Williams M, Kwoh CK and Hunter DJ: Observational study of the impact of an individualized multidisciplinary chronic care program for hip and knee osteoarthritis treatment on willingness for surgery. Int J Rheum Dis. 20:1383–1392. 2017. View Article : Google Scholar : PubMed/NCBI
14	Adatia A, Rainsford KD and Kean WF: Osteoarthritis of the knee and hip. Part I: Aetiology and pathogenesis as a basis for pharmacotherapy. J Pharm Pharmacol. 64:617–625. 2012. View Article : Google Scholar : PubMed/NCBI
15	Legré-Boyer V: Viscosupplementation: Techniques, indications, results. Orthop Traumatol Surg Res. 101 (Suppl):S101–S108. 2015. View Article : Google Scholar : PubMed/NCBI
16	Chin KY: The spice for joint inflammation: Anti-inflammatory role of curcumin in treating osteoarthritis. Drug Des Devel Ther. 10:3029–3042. 2016. View Article : Google Scholar : PubMed/NCBI
17	Sivordova LE, Zavodovsky BV, Polyakova JV and Akhverdyan YR: Evidence of feasibility etoricoxib therapy in osteoarthritis in elderly patients. Adv Gerontol. 29:286–290. 2016.(In Russian). PubMed/NCBI
18	Moskowitz RW: Role of collagen hydrolysate in bone and joint disease. Semin Arthritis Rheum. 30:87–99. 2000. View Article : Google Scholar : PubMed/NCBI
19	Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, et al: NCBI GEO: Archive for functional genomics data sets - update. Nucleic Acids Res. 41(D1): D991–D995. 2013. View Article : Google Scholar : PubMed/NCBI
20	Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W and Smyth GK: limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43:e472015. View Article : Google Scholar : PubMed/NCBI
21	Langfelder P and Horvath S: WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
22	Yu G, Wang LG, Han Y and He QY: clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
23	Han H, Cho JW, Lee S, Yun A, Kim H, Bae D, Yang S, Kim CY, Lee M, Kim E, et al: TRRUST v2: An expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res. 46D:D380–D386. 2018. View Article : Google Scholar
24	Yi Y, Zhao Y, Li C, Zhang L, Huang H, Li Y, Liu L, Hou P, Cui T, Tan P, et al: RAID v2.0: An updated resource of RNA-associated interactions across organisms. Nucleic Acids Res. 45D:D115–D118. 2017. View Article : Google Scholar
25	Pereira D, Ramos E and Branco J: Osteoarthritis. Osteoarthritis Acta Med Port. 28:99–106. 2015. View Article : Google Scholar : PubMed/NCBI
26	Goldring MB and Goldring SR: Osteoarthritis. J Cell Physiol. 213:626–634. 2007. View Article : Google Scholar : PubMed/NCBI
27	Beyer C, Zampetaki A, Lin NY, Kleyer A, Perricone C, Iagnocco A, Distler A, Langley SR, Gelse K, Sesselmann S, et al: Signature of circulating microRNAs in osteoarthritis. Ann Rheum Dis. 74:e182015. View Article : Google Scholar : PubMed/NCBI
28	Rousseau JC, Sornay-Rendu E, Bertholon C, Garnero P and Chapurlat R: Serum periostin is associated with prevalent knee osteoarthritis and disease incidence/progression in women: The OFELY study. Osteoarthritis Cartilage. 23:1736–1742. 2015. View Article : Google Scholar : PubMed/NCBI
29	Racine J and Aaron RK: Pathogenesis and epidemiology of osteoarthritis. R I Med J. 96:19–22. 2013.
30	Saito T and Tanaka S: Molecular mechanisms underlying osteoarthritis development: Notch and NF-κB. Arthritis Res Ther. 19:942017. View Article : Google Scholar : PubMed/NCBI
31	Zhong JH, Li J, Liu CF, Liu N, Bian RX, Zhao SM, Yan SY and Zhang YB: Effects of microRNA-146a on the proliferation and apoptosis of human osteoarthritis chondrocytes by targeting TRAF6 through the NF-κB signalling pathway. Biosci Rep. 37:372017. View Article : Google Scholar
32	Xu L, Sun C, Zhang S, Xu X, Zhai L, Wang Y, Wang S, Liu Z, Cheng H, Xiao M, et al: Sam68 promotes NF-κB activation and apoptosis signaling in articular chondrocytes during osteoarthritis. Inflamm Res. 64:895–902. 2015. View Article : Google Scholar : PubMed/NCBI
33	Zhou X, Luo D, Sun H, Qi Y, Xu W, Jin X, Li C, Lin Z and Li G: miR-132-3p regulates ADAMTS-5 expression and promotes chondrogenic differentiation of rat mesenchymal stem cells. J Cell Biochem. 119:2579–2587. 2018. View Article : Google Scholar : PubMed/NCBI
34	Li ZC, Han N, Li X, Li G, Liu YZ, Sun GX, Wang Y, Chen GT and Li GF: Decreased expression of microRNA-130a correlates with TNF-α in the development of osteoarthritis. Int J Clin Exp Pathol. 8:2555–2564. 2015.PubMed/NCBI
35	Meng X, Zhu Y, Tao L, Zhao S and Qiu S: miR-590-3p mediates melatonin-induced cell apoptosis by targeting septin 7 in the human osteoblast cell line hFOB 1.19. Mol Med Rep. 17:7202–7208. 2018.PubMed/NCBI
36	Gu R, Liu N, Luo S, Huang W, Zha Z and Yang J: MicroRNA-9 regulates the development of knee osteoarthritis through the NF-kappaB1 pathway in chondrocytes. Medicine (Baltimore). 95:e43152016. View Article : Google Scholar : PubMed/NCBI
37	Kobayashi H, Chang SH, Mori D, Itoh S, Hirata M, Hosaka Y, Taniguchi Y, Okada K, Mori Y, Yano F, et al: Biphasic regulation of chondrocytes by Rela through induction of anti-apoptotic and catabolic target genes. Nat Commun. 7:133362016. View Article : Google Scholar : PubMed/NCBI
38	Rigoglou S and Papavassiliou AG: The NF-κB signalling pathway in osteoarthritis. Int J Biochem Cell Biol. 45:2580–2584. 2013. View Article : Google Scholar : PubMed/NCBI
39	Cheng C, Shan W, Huang W, Ding Z, Cui G, Liu F, Lu W, Xu J, He W and Yin Z: ACY-1215 exhibits anti-inflammatory and chondroprotective effects in human osteoarthritis chondrocytes via inhibition of STAT3 and NF-κB signaling pathways. Biomed Pharmacother. 109:2464–2471. 2019. View Article : Google Scholar : PubMed/NCBI
40	Andrés RM, Payá M, Montesinos MC, Ubeda A, Navalón P, Herrero M, Vergés J and Terencio MC: Potential antipsoriatic effect of chondroitin sulfate through inhibition of NF-κB and STAT3 in human keratinocytes. Pharmacol Res. 70:20–26. 2013. View Article : Google Scholar : PubMed/NCBI